1
|
Aran S, Zahri S, Asadi A, Khaksar F, Abdolmaleki A. Hair follicle stem cells differentiation into bone cells on collagen scaffold. Cell Tissue Bank 2020; 21:181-188. [PMID: 32016616 DOI: 10.1007/s10561-020-09812-9] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2019] [Accepted: 01/24/2020] [Indexed: 12/17/2022]
Abstract
The hair follicle is a dynamic structure which contains different niches for stem cells, therefore; it has been considered as valuable and rich sources of stem cells, due to easy access, multipotency and non-oncogenic properties. In the present study, the differentiation capacities of hair follicle stem cells into bone cells on the natural collagen scaffolds were investigated. The stem cells were extracted from the hair follicle bulge area of male Wistar rats' whisker and cultured until 3rd passage, then osteogenic differentiations were induced by culturing the cells in the specific osteogenic medium. After 3 weeks, the differentiation parameters, including morphological changes, levels of calcification and expression of the bone specific genes were detected. The hydrogel preparation and scaffold fabrication was carried out using the extracted collagen and was studied by scanning electron microscope. Comparison of the stem cells' growth and changes on the scaffold and non-scaffold conditions showed that, in the both situation, the cells revealed differentiation signs of osteocytes, including large and cubic morphology with a star-shaped nucleus. Staining by Alizarin-red and Von-Kossa methods showed the presence of red and black calcium mass on the scaffold. Expression of the osteopontin and alkaline phosphatase genes confirmed the differentiation. Considerable porosity in the surface of the scaffold was recorded by scanning electron microscopy, which made it convenient for cells' attachment and growth. The data showed that the bulge stem cells possess significant capacity for osteoblastic differentiation and collagen scaffolds were found to be an appropriate matrix for growth and differentiation of the cell.
Collapse
Affiliation(s)
- Saeideh Aran
- Department of Biology, Faculty of Science, University of Mohaghegh Ardabili, Ardabil, Iran
| | - Saber Zahri
- Department of Biology, Faculty of Science, University of Mohaghegh Ardabili, Ardabil, Iran.
| | - Asadollah Asadi
- Department of Biology, Faculty of Science, University of Mohaghegh Ardabili, Ardabil, Iran
| | - Fatemeh Khaksar
- Department of Biology, Faculty of Science, University of Mohaghegh Ardabili, Ardabil, Iran
| | - Arash Abdolmaleki
- Department of Engineering Sciences, Faculty of Advanced Technologies, University of Mohaghegh Ardabili, Namin, Iran
- Bio Science and Biotechnology Research Center (BBRC), Sabalan University of Advanced Technologies (SUAT), Namin, Iran
| |
Collapse
|
4
|
Li P, Liu F, Wu C, Jiang W, Zhao G, Liu L, Bai T, Wang L, Jiang Y, Guo L, Qi X, Kou J, Fan R, Hao D, Lan S, Li Y, Liu JY. Feasibility of human hair follicle-derived mesenchymal stem cells/CultiSpher(®)-G constructs in regenerative medicine. Cell Tissue Res 2015; 362:69-86. [PMID: 25948482 DOI: 10.1007/s00441-015-2182-z] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2014] [Accepted: 03/25/2015] [Indexed: 12/30/2022]
Abstract
The use of human mesenchymal stem cells (hMSCs) in cell therapies has increased the demand for strategies that allow efficient cell scale-up. Preliminary data on the three-dimensional (3D) spinner culture describing the potential use of microcarriers for hMSCs culture scale-up have been reported. We exploited a rich source of autologous stem cells (human hair follicle) and demonstrated the robust in vitro long-term expansion of human hair follicle-derived mesenchymal stem cells (hHF-MSCs) by using CultiSpher(®)-G microcarriers. We analyzed the feasibility of 3D culture by using hHF-MSCs/CultiSpher(®)-G microcarrier constructs for its potential applicability in regenerative medicine by comparatively analyzing the performance of hHF-MSCs adhered to the CultiSpher(®)-G microspheres in 3D spinner culture and those grown on the gelatin-coated plastic dishes (2D culture), using various assays. We showed that the hHF-MSCs seeded at various densities quickly adhered to and proliferated well on the microspheres, thus generating at least hundreds of millions of hHF-MSCs on 1 g of CultiSpher(®)-G within 12 days. This resulted in a cumulative cell expansion of greater than 26-fold. Notably, the maximum and average proliferation rates in 3D culture were significantly greater than that of the 2D culture. However, the hHF-MSCs from both the cultures retained surface marker and nestin expression, proliferation capacity and differentiation potentials toward adipocytes, osteoblasts and smooth muscle cells and showed no significant differences as evidenced by Edu incorporation, cell cycle, colony formation, apoptosis, biochemical quantification and qPCR assays.
Collapse
Affiliation(s)
- Pengdong Li
- Department of Pathobiology, Key Laboratory of Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun, Jilin, 130021, People's Republic of China.,Department of Toxicology, School of Preventive Medicine, Jilin University, Changchun, Jilin, 130021, People's Republic of China
| | - Feilin Liu
- Department of Pathobiology, Key Laboratory of Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun, Jilin, 130021, People's Republic of China
| | - Chunling Wu
- Harbin Veterinary Research Institute, CAAS-Michigan State University Joint Laboratory of Innate Immunity, State Key Laboratory of Veterinary Biotechnology, Chinese Academy of Agricultural Sciences, Maduan Street 427, Nangang District, Harbin, 150001, People's Republic of China
| | - Wenyue Jiang
- Department of Analytical Chemistry, School of Pharmaceutical Sciences, Jilin University, Changchun, Jilin, 130021, People's Republic of China
| | - Guifang Zhao
- Department of Pathobiology, Key Laboratory of Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun, Jilin, 130021, People's Republic of China
| | - Li Liu
- Department of Pathobiology, Key Laboratory of Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun, Jilin, 130021, People's Republic of China
| | - Tingting Bai
- Department of Pathobiology, Key Laboratory of Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun, Jilin, 130021, People's Republic of China
| | - Li Wang
- Department of Pathobiology, Key Laboratory of Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun, Jilin, 130021, People's Republic of China
| | - Yixu Jiang
- Department of Pathobiology, Key Laboratory of Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun, Jilin, 130021, People's Republic of China
| | - Lili Guo
- Department of Pathology, Jilin Cancer Hospital, Changchun, Jilin, 130012, People's Republic of China
| | - Xiaojuan Qi
- Department of Pathobiology, Key Laboratory of Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun, Jilin, 130021, People's Republic of China
| | - Junna Kou
- Department of Pathobiology, Key Laboratory of Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun, Jilin, 130021, People's Republic of China
| | - Ruirui Fan
- Department of Pathobiology, Key Laboratory of Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun, Jilin, 130021, People's Republic of China
| | - Deshun Hao
- Department of Pathobiology, Key Laboratory of Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun, Jilin, 130021, People's Republic of China
| | - Shaowei Lan
- Department of Pathobiology, Key Laboratory of Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun, Jilin, 130021, People's Republic of China
| | - Yulin Li
- Department of Pathobiology, Key Laboratory of Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun, Jilin, 130021, People's Republic of China
| | - Jin Yu Liu
- Department of Pathobiology, Key Laboratory of Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun, Jilin, 130021, People's Republic of China. .,Department of Toxicology, School of Preventive Medicine, Jilin University, Changchun, Jilin, 130021, People's Republic of China.
| |
Collapse
|
5
|
Semalty A, Semalty M, Joshi GP, Rawat MSM. Techniques for the discovery and evaluation of drugs against alopecia. Expert Opin Drug Discov 2012; 6:309-21. [PMID: 22647205 DOI: 10.1517/17460441.2011.553831] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
INTRODUCTION Hair care, color and style play an important role in physical appearance and self-perception. Hair loss or alopecia is a common dermatological and affective disorder. Factors contributing to alopecia include genetic predisposition, hormonal factors, disease status, side effects of chemotherapeutic agents and stress. To keep pace with the demand for drugs for alopecia, attempts are being made to explore drugs with hair-growth-promotion activity. To explore and evaluate these, it is necessary to be familiar with the basics and the availability and suitability of techniques and experimental models of hair growth activity assessment. AREAS COVERED Basic and advanced techniques and models for assessing hair growth activity. A variety of pharmacological models of hair growth are reviewed. This review will help in selecting a suitable, relevant, inexpensive, easy and reliable model for hair growth assessment. EXPERT OPINION There is a need to identify the genes involved in hair follicle growth for the production of more effective animal models of the disorder. Standardization of pharmacological models will also be essential for better comparison and validation of results. Recently developed hair follicle organ culture models are a suitable, relevant and inexpensive alternative to traditional whole-animal pharmacological models and will, largely, replace whole-animal systems in the future.
Collapse
Affiliation(s)
- Ajay Semalty
- H.NB Garhwal (Central) University Srinagar, Department of Pharmaceutical Sciences, PB No.-106, Garhwal 246174, Uttarakhand, India +91 1346 211502 ; +91 1346 252174 ;
| | | | | | | |
Collapse
|
7
|
Hanif M, Rosengardten Y, Sagelius H, Rozell B, Eriksson M. Differential expression of A-type and B-type lamins during hair cycling. PLoS One 2009; 4:e4114. [PMID: 19122810 PMCID: PMC2606029 DOI: 10.1371/journal.pone.0004114] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2008] [Accepted: 12/02/2008] [Indexed: 11/18/2022] Open
Abstract
Multiple genetic disorders caused by mutations that affect the proteins lamin A and C show strong skin phenotypes. These disorders include the premature aging disorders Hutchinson-Gilford progeria syndrome and mandibuloacral dysplasia, as well as restrictive dermopathy. Prior studies have shown that the lamin A/C and B proteins are expressed in skin, but little is known about their normal expression in the different skin cell-types and during the hair cycle. Our immunohistochemical staining for lamins A/C and B in wild-type mice revealed strong expression in the basal cell layer of the epidermis, the outer root sheath, and the dermal papilla during all stages of the hair cycle. Lower expression of both lamins A/C and B was seen in suprabasal cells of the epidermis, in the hypodermis, and in the bulb of catagen follicles. In addition, we have utilized a previously described mouse model of Hutchinson-Gilford progeria syndrome and show here that the expression of progerin does not result in pronounced effects on hair cycling or the expression of lamin B.
Collapse
Affiliation(s)
- Mubashir Hanif
- The Folkhälsan Institute of Genetics, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland
| | - Ylva Rosengardten
- Department of Biosciences and Nutrition, Karolinska Institutet, Karolinska University Hospital, Huddinge, Novum, Stockholm, Sweden
| | - Hanna Sagelius
- Department of Biosciences and Nutrition, Karolinska Institutet, Karolinska University Hospital, Huddinge, Novum, Stockholm, Sweden
| | - Björn Rozell
- Clinical Research Center, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden
| | - Maria Eriksson
- Department of Biosciences and Nutrition, Karolinska Institutet, Karolinska University Hospital, Huddinge, Novum, Stockholm, Sweden
- * E-mail:
| |
Collapse
|
9
|
Jimenez JJ, Roberts SM, Mejia J, Mauro LM, Munson JW, Elgart GW, Connelly EA, Chen Q, Zou J, Goldenberg C, Voellmy R. Prevention of chemotherapy-induced alopecia in rodent models. Cell Stress Chaperones 2008; 13:31-8. [PMID: 18347939 PMCID: PMC2666212 DOI: 10.1007/s12192-007-0005-1] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2007] [Revised: 07/18/2007] [Accepted: 07/19/2007] [Indexed: 11/30/2022] Open
Abstract
Alopecia (hair loss) is experienced by thousands of cancer patients every year. Substantial-to-severe alopecia is induced by anthracyclines (e.g., adriamycin), taxanes (e.g., taxol), alkylating compounds (e.g., cyclophosphamide), and the topisomerase inhibitor etoposide, agents that are widely used in the treatment of leukemias and breast, lung, ovarian, and bladder cancers. Currently, no treatment appears to be generally effective in reliably preventing this secondary effect of chemotherapy. We observed in experiments using different rodent models that localized administration of heat or subcutaneous/intradermal injection of geldanamycin or 17-(allylamino)-17-demethoxygeldanamycin induced a stress protein response in hair follicles and effectively prevented alopecia from adriamycin, cyclophosphamide, taxol, and etoposide. Model tumor therapy experiments support the presumption that such localized hair-saving treatment does not negatively affect chemotherapy efficacy.
Collapse
Affiliation(s)
| | - Stephen M. Roberts
- Center for Environmental and Human Toxicology, Department of Physiological Sciences, University of Florida, Gainesville, FL USA
| | - Jessica Mejia
- Department of Biochemistry and Molecular Biology, University of Miami, Miami, FL USA
| | - Lucia M. Mauro
- Department of Biochemistry and Molecular Biology, University of Miami, Miami, FL USA
| | - John W. Munson
- Center for Environmental and Human Toxicology, Department of Physiological Sciences, University of Florida, Gainesville, FL USA
| | - George W. Elgart
- Department of Dermatology and Cutaneous Surgery, University of Miami, Miami, FL USA
| | - Elizabeth Alvarez Connelly
- Department of Dermatology and Cutaneous Surgery, University of Miami, Miami, FL USA
- Department of Pediatrics, University of Miami, Miami, FL USA
| | - Qingbin Chen
- School of Pharmaceutical Science, Zhongshan Medical College, Sun Yat-sen University, Guangzhou, People’s Republic of China
| | - Jiangying Zou
- Guangzhou Institute of Biomedicine and Health, Guangzhou, People’s Republic of China
| | | | - Richard Voellmy
- Department of Biochemistry and Molecular Biology, University of Miami, Miami, FL USA
- HSF Pharmaceuticals S.A., Av. des Cerisiers 39B, 1009 Pully, Switzerland
| |
Collapse
|